Ken Lund

20PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersPainExercise physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 31, 2026
Chronic opioid use and the risk of infections and death in patients with inflammatory bowel disease: a nationwide cohort study based on real-world data.

|May 04, 2026
Analgesic Use in Patients with Mild Inflammatory Bowel Disease-A Nationwide Cohort Study Based on Prescription Data.

|Mar 28, 2026
The IBD-FITT Study-Moderate-Intensity Exercise for Patients with Active Inflammatory Bowel Disease: An Open-Label Randomized Controlled Trial.

Ken Lund, Torben Knudsen, Jens Kjeldsen

|Nov 27, 2025
Risk of Sequelae Following COVID-19 Infection: A Nationwide Study Focusing on Risk Factors and Long-Term Impacts.

Simon Kjeldsen, Jan Nielsen, Bente Mertz Nørgård

|Oct 10, 2025
In Bio-naive IBD Patients, Does Clinical Response After Induction Therapy With Biologics Predict Treatment Failure Within Two Years? - Using Two Danish Study Populations.

Ken Lund, Jan Nielsen, Caroline Theilgaard Thorarinsson

|Jul 21, 2025
REPLY: Breaking Conventions: Innovative Reflections on the Medication Use Research of IBD in Adults and the Elderly.

Ken Lund, Jan Nielsen, Jacob Broder Brodersen

Pageof 4

Frequent Collaborators

18 joint publications

Bente Mertz Nørgård

15 joint publications

Jens Kjeldsen

14 joint publications

Torben Knudsen

9 joint publications

Jan Nielsen